Louisiana 2020 Regular Session

Louisiana House Bill HB552

Introduced
2/28/20  
Introduced
2/28/20  
Refer
2/28/20  
Refer
3/9/20  

Caption

Provides relative to liberative prescription

Impact

The impact of HB552 on state laws primarily revolves around its provisions regarding the timeframe for filing delictual actions and the restrictions on medical expense recoveries. By standardizing the prescriptive period to two years, the bill streamlines the legal processes associated with personal injury claims. The provision limiting the recovery of medical expenses could reduce the amount claimants receive, potentially influencing the decisions of individuals contemplating legal action, particularly in personal injury scenarios.

Summary

House Bill 552 aims to amend existing laws concerning delictual actions by establishing a uniform two-year prescriptive period for claims. The bill specifically limits the recovery of medical or healthcare expenses to the actual amounts paid or incurred by the claimant. This change is significant as it replaces the prior one-year prescriptive period with a more extended two-year limit, while retaining existing exceptions for certain cases, such as those involving permanent disabilities.

Sentiment

The sentiment surrounding HB552 appears mixed, with proponents likely viewing the bill as a necessary reform for balancing the interests of the healthcare system and those pursuing claims. Opponents may express concern that limiting the recovery of medical expenses could undermine the ability of injured parties to obtain full compensation for their costs, particularly in cases involving significant medical needs. This dichotomy indicates that discussions around the bill may involve considerable debate over the implications for claimants and the healthcare system alike.

Contention

Notable points of contention regarding HB552 include the proposed repeal of the one-year prescriptive period and the new limitations on recovery of medical expenses. Critics might argue that while a two-year period may benefit some claimants, it could also lead to inequities, particularly for those who require time to assess the extent of their injuries and associated medical costs. Furthermore, the implications of limiting recoveries strictly to documented expenses could disadvantage individuals facing high medical bills or ongoing treatments due to their injuries.

Companion Bills

No companion bills found.

Previously Filed As

LA SB168

Provides for liberative prescription on mineral leases on state property. (8/1/25)

LA SB2

Extends prescriptive period for certain delictual actions from one to two years. (1/1/21) (OR SEE FISC NOTE GF EX)

LA SB3

Provides for the Litigation Reduction Act. (1/1/21) (OR SEE FISC NOTE GF EX)

LA HB44

Enacts the Omnibus Premium Reduction Act of 2020 (Item #40) (RE SEE FISC NOTE GF EX)

LA HB66

Enacts the Citizens' Premium Reduction Act (Item #40) (EG SEE FISC NOTE GF EX)

LA HB42

Enacts the Omnibus Premium Reduction Act of 2020 (Item #40)

LA SB29

Provides relative to certain civil actions, civil liability, damages, and procedures. (1/1/21) (OR SEE FISC NOTE GF EX)

LA HB43

Makes revisions to the Omnibus Premium Reduction Act of 2020 (Item #40)

LA SB28

Provides relative to certain civil liability, actions, damages, and procedures. (1/1/21) (OR SEE FISC NOTE GF EX)

LA H3117

Prescriptions

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

CA AB577

Health care coverage: antisteering.

RI H8318

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

RI S2889

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

HI HB2225

Relating To Health.

HI SB2751

Relating To Workers' Compensation.

RI H5866

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.

RI S0795

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.